Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

US Patent 12226471 · Granted Feb 18, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide vaccine based on a new universal influenza a hemagglutinin head domain e2025
Methods of lipid nanoparticle manufacture and compositions derived therefrom2025
Human monoclonal antibodies to enterovirus D682025
Nucleoside modified mRNA and uses thereof2025
Conserved region T cell vaccines for coronavirus and methods of use2025
Human monoclonal antibodies to a new universal influenza A hemagglutinin head do2025
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (2025
Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses2025
Compositions for inducing an immune response against zika virus2024
Nucleoside-modified RNA for inducing an adaptive immune response2024
Purification and purity assessment of RNA molecules synthesized with modified nu2024
Human monoclonal antibodies against yellow fever virus and uses therefor2024